Skip to main content

Cardiovascular Information System (CVIS) Market is Growing at a Healthy CAGR of 8.30% During Forecast to 2025

Market Overview:
In the recent years, cardiovascular information systems have undergone a transformation to meet demands for better interoperability, changing healthcare IT landscape and infrastructure and need to meet healthcare reform requirements. Various market players are either undertaking collaborative efforts or launching new products and therefore aiding in the growth of the cardiovascular information systems industry.
The global Cardiovascular Information System (CVIS) Market Trends  is poised to reach the valuation of USD 1,343.26 million by 2025, as per the latest report by Market Research Future (MRFR). The market can grow immensely at 8.30% CAGR over the forecast period (2018-2025).

Get a Free Sample @ https://www.marketresearchfuture.com/sample_request/7721

Various factors are propelling the cardiovascular information system market growth. Some of these factors, according to the Market Research Future report, include increasing prevalence of various cardiovascular diseases and disorders such as ischemic heart disease, arrhythmias, and cardiac failure, various initiatives taken by the government for digitizing patient data, and technological advancements in healthcare IT. Additional factors pushing market growth include increasing need for productive data management tools in cardiac care departments and increasing rate of medication errors. On the contrary, technical complexities and high costs related to CVIS that can result in hesitation in its adoption among hospitals are factors that may impede the cardiovascular information system market
growth over the forecast period.
Competitive Analysis:
  • Carestream Health
  • Scimage, Inc
  • Koninklijke Philips N.V
  • Cerner Corporation
  • Epic Systems Corporation
  • Digisonics Inc.
  • Fujifilm Holdings Corporation
  • LUMEDX
  • Agfa-Gevaert N.V.
  • IBM Health
  • General Electric Company
  • McKesson Corporation
  • Siemens Healthineers

Segmentation Analysis:
  • The cardiovascular information system (CVIS) market is segmented by component, deployment, application, and end-user.
  • By component, software held close to 67.9% share of the CVIS market in 2017, followed by services the second largest market and hardware the least market share.
  • By deployment, web/cloud-based held the largest market share in 2017, while the on-premise segment held second largest share.
  • Among applications, cardiac and peripheral catheterization held 32.4% share in 2017, followed by echocardiography, hemodynamics monitoring, electrophysiology, vascular ultrasound, nuclear cardiology, ECG/stress/Holter management, and others.
  • Hospitals & clinics was the biggest market end-user in 2017 with a respectable 48.2% share, followed by diagnostic laboratories, cardiac cath labs, and others.

Regional Analysis:
The geographical analysis of the cardiovascular information system (CVIS) market encompasses fore regions - Americas, Europe, Asia Pacific, and the Middle East & Africa (MEA). Americas, placed at the dominant position, held 37.6% market share in 2017. It is prognosticated to maintain its dominance through the review period and value at USD 481.04 Mn towards the end of 2025. Healthcare services providers leverage mHealth and big data for early detection of CVDs in the region which is expected to provide impetus to market growth. On the other hand, Europe is likely to exhibit a steady CAGR between 2018 and 2025.




Labels:

Comments

Post a Comment

Popular posts from this blog

Covid 19 Analysis on Respiratory Therapeutic Devices Market Analysis and Forecast to 2023

Market Overview: The Global Respiratory Therapeutic Devices Market is predicted to scale to new heights and expand at a CAGR of 10.8% over the forecast period of 2017-2023, asserts Market Research Future (MRFR) in an in-depth study.                   The growth of the Global Covid 19 Analysis on Respiratory Therapeutic Devices Market Analysis   is primarily led by the recent surge in the incidence of chronic respiratory diseases such as asthma, COPD, and sleep disorder breathing. As per the estimates of the World Health Organization (WHO), approximately 235 Mn people suffered from asthma in 2017 across the globe. The growing burden of chronic respiratory diseases (CRDs) induces strong demand for respiratory therapeutic devices within the market. Moreover, with the increase in the global aging population, there is a greater need for respiratory therapeutic devices.     ...
Post a Comment
Read more

Antibody Drug Conjugate Market is Presumed to Grow at a Reliable CAGR of 19% During Forecast to 2023

Antibody Drug Conjugate Market Analysis: Various factors are adding to the global antibody drug conjugate market share. These factors, as per the new MRFR report, include advances in medical technology, rising cases of cancer, growing obese population, and increasing aging population. Additional factors adding market growth include increasing collaborations between biotechnology companies, biopharmaceuticals, and research institutes, rising R&D on oncology diseases, increasing research on advanced drug discoveries, rising number of research on antibody therapies, and preclinical research. The global Antibody Drug Conjugate Market Share is likely to grow at a 19% CAGR between 2017- 2023 , reveals the new Market Research Future (MRFR) report. Antibody drug conjugates are new-age therapeutic agents that have three parts- a chemical linker to attach cytotoxic agents to antibodies, cytotoxic agents for killing target cancer cells, and specific antibodies for binding. Lymphoma, mult...
Post a Comment
Read more

Desalting and Buffer Exchange Market is Growing at a Healthy CAGR of 10.5% During Forecast to 2023

Market Highlights: The Global Desalting and Buffer Exchange Market is anticipated to have held a market value of USD 615.20 million in the year 2017 and is expected to grow at a CAGR of 10.5% during the forecast period. Desalting and buffer exchange play a key role in biotechnological companies. Buffer exchange is used to place a protein solution into a more suitable buffer before applications such as electrophoresis, ion exchange, affinity chromatography among others. Get a Free Sample @ https://www.marketresearchfuture.com/sample_request/6633 Buffer exchange is the term used when one set of buffer salts in a sample is exchanged by another more appropriate buffer set. The rising demand for monoclonal antibodies, growing research and development expenditure by the biopharmaceutical companies, and rising focus on proteomic and genomic research is anticipated to boost the growth of the market over the forecast period. However, the dearth of skilled professionals is excepted to ...
Post a Comment
Read more